Connection

Contact Us
If you have any questions or feedback please contact us.

Search Results to Gregory G Schwartz

This is a "connection" page, showing the details of why an item matched the keywords from your search.

Search Results

Schwartz, Gregory

One or more keywords matched the following items that are connected to Schwartz, Gregory

Item Type	Name
Academic Article	Applying the results of large clinical trials in the management of acute myocardial infarction.
Academic Article	Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial.
Academic Article	Early initiation of treatment with statins in acute coronary syndromes.
Academic Article	Rationale and design of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study that evaluates atorvastatin in unstable angina pectoris and in non-Q-wave acute myocardial infarction.
Academic Article	Pharmacoeconomic evaluation of the effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes.
Academic Article	Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study.
Academic Article	High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial.
Academic Article	The case for intensive statin therapy after acute coronary syndromes.
Academic Article	High-density lipoprotein cholesterol as a risk factor and target of therapy after acute coronary syndrome.
Academic Article	Exploring new strategies for the management of acute coronary syndromes.
Academic Article	Statins for acute coronary syndrome.
Academic Article	Association of perioperative ?-blockade with mortality and cardiovascular morbidity following major noncardiac surgery.
Academic Article	High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study.
Academic Article	Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes: a meta-analysis of randomized controlled trials.
Academic Article	Perioperative beta-blockade: a survey of physician attitudes in the department of Veterans Affairs.
Academic Article	High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial.
Concept	Myocardial Infarction
Academic Article	Mortality after perioperative ?-blocker use in noncardiac surgery-reply.
Academic Article	Evaluation of the dual peroxisome proliferator-activated receptor a/? agonist aleglitazar to reduce cardiovascular events in patients with acute coronary syndrome and type 2 diabetes mellitus: rationale and design of the AleCardio trial.
Academic Article	Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial.
Academic Article	Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial.
Academic Article	Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial.
Academic Article	Pioglitazone for secondary prevention after ischemic stroke and transient ischemic attack: rationale and design of the Insulin Resistance Intervention after Stroke Trial.
Academic Article	Statins for acute coronary syndrome.
Academic Article	Effects of the dual peroxisome proliferator-activated receptor activator aleglitazar in patients with Type 2 Diabetes mellitus or prediabetes.
Academic Article	Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
Academic Article	Cochrane corner: early statin therapy in acute coronary syndromes--what is the clinical benefit?
Academic Article	Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease.
Academic Article	Aldosterone Does Not Predict Cardiovascular Events Following Acute Coronary Syndrome in Patients Initially Without Heart Failure.
Grant	Diet-Induced Insulin Resistance and Myocardial Ischemia in Pigs
Grant	Diet-Induced Insulin Resistance and Myocardial Ischemia in Pigs
Academic Article	Adiponectin, Free Fatty Acids, and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Acute Coronary Syndrome.
Academic Article	Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome: A Secondary Analysis of the VISTA-16 Trial.
Academic Article	Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial.
Academic Article	Effect of selective BET protein inhibitor apabetalone on cardiovascular outcomes in patients with acute coronary syndrome and diabetes: Rationale, design, and baseline characteristics of the BETonMACE trial.
Academic Article	Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial.
Academic Article	Association of high-density lipoprotein particle concentration with cardiovascular risk following acute coronary syndrome: A case-cohort analysis of the dal-Outcomes trial.
Academic Article	Effect of Apabetalone Added to Standard Therapy on Major Adverse Cardiovascular Events in Patients With Recent Acute Coronary Syndrome and Type 2 Diabetes: A Randomized Clinical Trial.
Academic Article	Myocardial Infarction and Evolocumab.
Academic Article	Effect of Alirocumab on Incidence of Atrial Fibrillation After Acute Coronary Syndromes: Insights from the ODYSSEY OUTCOMES Trial.
Academic Article	Alirocumab and Cardiovascular Outcomes in Patients With Previous Myocardial Infarction: Prespecified Subanalysis From ODYSSEY OUTCOMES.
Academic Article	Proprotein convertase subtilisin/kexin type 9 inhibition after acute coronary syndrome or prior myocardial infarction.
Academic Article	Inclisiran and cardiovascular events: a patient-level analysis of phase III trials.
Academic Article	Projected Outcomes of Optimized Statin and Ezetimibe Therapy in US Military Veterans with Coronary Artery Disease.

Search Criteria

Infarction